Pharmaway Invest ApS: Financial statements 2024
CVR: 38585126
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharmaway Invest ApS (CVR 38585126) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -28,750 and a net result of DKK -38,583 compared with DKK -19,577 the year before. Equity in the 2024 report amounted to DKK 47,988,357. The solvency ratio was 99.5%.
- Gross Profit
- DKK -28,750
- Profit/Loss
- DKK -38,583
- Equity
- DKK 47,988,357
- Total Assets
- DKK 48,240,850
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -29K | -39K | 48M | - |
| 2023 | - | -16K | -20K | 48M | - |
| 2022 | - | -14K | -18K | 48M | - |
| 2021 | - | -22K | -25K | 48.1M | - |
| 2020 | - | -23K | -25K | 36.1M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharmaway Invest ApS has published its annual report for 2023. Gross profit came to DKK -15,625, and the net result was DKK -19,577.
About Pharmaway Invest ApS
Pharmaway Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Niels Ebbe Ebbesen. The company's owners include Ebbelykke ApS, Hundekurven ApS and Ebfos Family Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -23,125 and a net result of DKK -43,449,506 compared with DKK -38,583 the year before. Equity in the 2025 report amounted to DKK 4,538,851.
